U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for diabetes and weight loss, according to a review of patient data published on Monday, the ...

In a report released today, Balaji Prasad from Barclays maintained a Buy rating on Teva Pharmaceutical (TEVA – Research Report), with a price target of $25.00. The company’s shares closed last Friday ...

Experts share their easy tips for saving on prescriptions. One of the easiest ways to save money on meds is to ask your ...

The FDA removed Wegovy, Ozempic, Mounjaro, and Zepbound from its drug shortage list for the first time in two years. The move ...

Neurocrine Biosciences, Inc.'s potential for growth in the biopharma sector is strong despite recent setbacks, making its ...

Teva Pharmaceutical Industries TEVA reported third-quarter 2024 adjusted earnings of 69 cents per share, which beat the Zacks ...

Consumers who bought generic drugs between 2010 and 2016 could see a refund, as Attorney General Michelle Henry announced a ...

US drug shortages have decreased from 323 to 277 as of September 2024, yet many essential drugs remain scarce, with 50% of ...

The campaign targeted key stakeholders, such as doctors and organizations involved in drug pricing and reimbursement, with ...

The fine of €462.6 million ($503 million) is believed to be the largest imposed on a pharma company for breaking antitrust ...